AMERIMMUNE PHARMACEUTICALS INC
10QSB, EX-27, 2000-08-14
BLANK CHECKS
Previous: AMERIMMUNE PHARMACEUTICALS INC, 10QSB, 2000-08-14
Next: BITSTREAM INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the registrant's
Form 10-QSB for the Quarter ended June 30, 2000 and is qualified in its
entirety to such form.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         842,716
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               870,748
<PP&E>                                          35,075
<DEPRECIATION>                                  14,545
<TOTAL-ASSETS>                                 894,318
<CURRENT-LIABILITIES>                          193,403
<BONDS>                                              0
                                0
                                          0
<COMMON>                                     2,152,143
<OTHER-SE>                                   2,930,244
<TOTAL-LIABILITY-AND-EQUITY>                   894,318
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               273,874
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 889
<INCOME-PRETAX>                              (274,763)
<INCOME-TAX>                                     1,600
<INCOME-CONTINUING>                          (276,363)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (276,363)
<EPS-BASIC>                                     (0.01)
<EPS-DILUTED>                                   (0.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission